+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Diabetes Devices and Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026

  • ID: 5359390
  • Report
  • June 2021
  • Region: Global
  • 100 pages
  • Infinium Global Research

FEATURED COMPANIES

  • Abbott Laboratories
  • Eli Lilly and Company
  • Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Medtronic PLC
  • Novo Nordisk A/S
The report on the global diabetes devices and drugs market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global diabetes devices and drugs market to grow with a CAGR of 6.5% over the forecast period from 2020-2026. The study on diabetes devices and drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.



The report on diabetes devices and drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global diabetes devices and drugs market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global diabetes devices and drugs market over the period of 2018 to 2026. Further, the Publisher's Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • The growing prevalence of diabetes due to population growth, aging, and urbanization
  • The rapidly changing lifestyles
  • Raising awareness about diabetes and diabetes management among patients
2) Restraints
  • Low awareness about diabetes management and monitoring devices in under-developed countries
3) Opportunities
  • Ongoing technological advancements and the introduction of advanced insulin delivery devices
Research Methodology

A) Primary Research

The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

1. Key Opinion Leaders associated with the publisher
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically includes:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global diabetes devices and drugs market is segmented on the basis of type, and end user.

The Global Diabetes Devices and Drugs Market by Type
  • Devices
  • Continuous Blood Glucose Monitoring Devices
  • Test Strips
  • Lancets
  • Self-monitoring Devices
  • Insulin Pens
  • Insulin Pumps
  • Others
  • Drugs
  • Insulin
  • Oral Hypoglycaemic Agents
  • Non-Insulin Injectable
The Global Diabetes Devices and Drugs Market by End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Centers
  • Self-Care
Company Profiles

The companies covered in the report include
  • Novo Nordisk A/S
  • Ypsomed AG
  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Eli Lilly and Company
  • Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Medtronic PLC
  • Becton, Dickinson and Company
  • Terumo Corporation
What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the diabetes devices and drugs market.
2. Complete coverage of all the segments in the diabetes devices and drugs market to analyze the trends, developments in the global market and forecast of market size up to 2026.
3. Comprehensive analysis of the companies operating in the global diabetes devices and drugs market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The Publisher's Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Eli Lilly and Company
  • Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Medtronic PLC
  • Novo Nordisk A/S
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Diabetes Devices and Drugs Market Highlights
2.2. Diabetes Devices and Drugs Market Projection
2.3. Diabetes Devices and Drugs Market Regional Highlights

3. Global Diabetes Devices and Drugs Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Diabetes Devices and Drugs Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Type
3.5.2. Growth Matrix Analysis by End User
3.5.3. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Diabetes Devices and Drugs Market

4. Diabetes Devices and Drugs Market Macro Indicator Analysis

5. Global Diabetes Devices and Drugs Market by Type
5.1. Devices
5.1.1. Continuous Blood Glucose Monitoring Devices
5.1.2. Test Strips
5.1.3. Lancets
5.1.4. Self-monitoring Devices
5.1.5. Insulin Pens
5.1.6. Insulin Pumps
5.1.7. Others
5.2. Drugs
5.2.1. Insulin
5.2.2. Oral Hypoglycaemic Agents
5.2.3. Non-Insulin Injectable

6. Global Diabetes Devices and Drugs Market by End User
6.1. Hospitals
6.2. Clinics
6.3. Ambulatory Surgical Centers
6.4. Home Care Centers
6.5. Self-Care

7. Global Diabetes Devices and Drugs Market by Region 2020-2026
7.1. North America
7.1.1. North America Diabetes Devices and Drugs Market by Type
7.1.2. North America Diabetes Devices and Drugs Market by End User
7.1.3. North America Diabetes Devices and Drugs Market by Country
7.2. Europe
7.2.1. Europe Diabetes Devices and Drugs Market by Type
7.2.2. Europe Diabetes Devices and Drugs Market by End User
7.2.3. Europe Diabetes Devices and Drugs Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Diabetes Devices and Drugs Market by Type
7.3.2. Asia-Pacific Diabetes Devices and Drugs Market by End User
7.3.3. Asia-Pacific Diabetes Devices and Drugs Market by Country
7.4. RoW
7.4.1. RoW Diabetes Devices and Drugs Market by Type
7.4.2. RoW Diabetes Devices and Drugs Market by End User
7.4.3. RoW Diabetes Devices and Drugs Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Diabetes Devices and Drugs Market
8.2. Companies Profiled
8.2.1. Novo Nordisk A/S
8.2.2. Ypsomed AG
8.2.3. Abbott Laboratories
8.2.4. Ascensia Diabetes Care Holdings AG
8.2.5. Eli Lilly and Company
8.2.6. Hoffmann-La Roche Ltd.
8.2.7. Johnson & Johnson
8.2.8. Medtronic PLC
8.2.9. Becton, Dickinson and Company
8.2.10. Terumo Corporation
Note: Product cover images may vary from those shown
  • Novo Nordisk A/S
  • Ypsomed AG
  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • Eli Lilly and Company
  • Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Medtronic PLC
  • Becton, Dickinson and Company
  • Terumo Corporation
Note: Product cover images may vary from those shown
Adroll
adroll